Abstract:Custom RNA base editing using the endogenous human Adenosine Deaminase Acting on RNA (ADAR) enzyme presents a promising approach for precision therapeutics, alleviating concerns of permanent DNA damage or immunogenicity from foreign bacterial proteins such as CRISPR/Cas. ADAR can be directed to act on therapeutic RNA targets by antisense guide RNAs (gRNAs) that create a substrate for ADAR′s adenosine-to-inosine (effectively A-to-G) deamination activity. Delivery of gRNAs via a DNA expression construct provided by Adeno-Associated Virus (AAV) might allow life-long duration of the therapy. However, a major challenge for RNA editing using gene-encoded gRNAs and endogenous levels of ADAR is achieving sufficient gRNA activity inside cells, especially in therapeutic situations where AAV delivery may provide as low as one viral genome per cell. Here we show that embedding antisense gRNAs into a U7 small nuclear RNA (snRNA) framework and adding hnRNP A1 binding domains greatly increases the efficiency of custom RNA editing. This increased editing efficiency allows for detectable RNA editing from a single genomic insertion of gRNA construct per cell, which enabled a pooled library screen of 750+ gRNA variations to further improve the SmOPT U7 hairpin system. The screen revealed critical residues responsible for RNA editing and generated new SmOPT and U7 hairpin variants that further boosted RNA editing. The final design, combined with an improved synthetic U7 promoter, resulted in up to 76% targeted editing with a single integrated copy of construct per cell, representing a 10- to 100-fold increase over existing circular gRNA approaches. Using systemic AAV delivery, we achieved an unprecedented 75% RNA editing in the total brain of a mouse model of Hurler syndrome. Our novel SmOPT U7 system also improved published antisense oligos for DMD exon skipping, currently in clinical trials, by up to 25-fold in differentiated myoblasts, and therefore represents a universal scaffold for ADAR-based RNA editing as well as other antisense RNA therapies.

A cytosine deaminase for programmable single-base RNA editing

RNA editing with CRISPR-Cas13

Programmable RNA base editing via targeted modifications

Precision RNA base editing with engineered and endogenous effectors

Robust RNA editing via recruitment of endogenous ADARs using circular guide RNAs

REPAIRx, a specific yet highly efficient programmable A > I RNA base editor

Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position

An improved SNAP-ADAR tool enables efficient RNA base editing to interfere with post-translational protein modification

Wobble base improves precision in RNA editing

Site-directed RNA editing: recent advances and open challenges

EditR: A Method to Quantify Base Editing from Sanger Sequencing

A Novel Engineered U7 Small Nuclear RNA Scaffold Greatly Increases and ADAR-Mediated Programmable RNA Base Editing

Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors

Creating RNA Specific C-to-U Editase from APOBEC3A by Separation of Its Activities on DNA and RNA Substrates

Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing

A circularly permuted CasRx platform for efficient, site-specific RNA editing

Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA

Site-directed RNA editing by harnessing ADARs: advances and challenges

Leveraging Small Molecule-Induced Aptazyme Cleavage for Directed A-to-I RNA Editing

Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs